Schrodinger, Inc. Share Holder Equity 2019-2024 | SDGR
Schrodinger, Inc. share holder equity from 2019 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
| Schrodinger, Inc. Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $549 |
| 2022 | $448 |
| 2021 | $557 |
| 2020 | $624 |
| 2019 | $98 |
| 2018 | $90 |
| Schrodinger, Inc. Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | $449 |
| 2024-06-30 | $474 |
| 2024-03-31 | $514 |
| 2023-12-31 | $549 |
| 2023-09-30 | $564 |
| 2023-06-30 | $611 |
| 2023-03-31 | $590 |
| 2022-12-31 | $448 |
| 2022-09-30 | $463 |
| 2022-06-30 | $493 |
| 2022-03-31 | $531 |
| 2021-12-31 | $557 |
| 2021-09-30 | $580 |
| 2021-06-30 | $606 |
| 2021-03-31 | $632 |
| 2020-12-31 | $624 |
| 2020-09-30 | $631 |
| 2020-06-30 | $296 |
| 2020-03-31 | $296 |
| 2019-12-31 | $98 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $90 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||